story of the week
Correlation of PD-L1 Tumor Expression and Treatment Outcomes in Patients With RCC Receiving Sunitinib or Pazopanib
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Clinical Cancer Research
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Correlation of PD-L1 Tumor Expression and Treatment Outcomes in Patients With Renal Cell Carcinoma Receiving Sunitinib or Pazopanib: Results From COMPARZ, a Randomized Controlled Trial
Clin. Cancer Res 2014 Dec 23;[EPub Ahead of Print], TK Choueiri, DJ Figueroa, AP Fay, S Signoretti, Y Liu, R Gagnon, K Deen, C Carpenter, P Benson, TH Ho, L Pandite, PL de Souza, T Powles, RJ MotzerFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.